| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 07/03/2008 | WO2008048773A9 Models of atherosclerosis, hyperlipidemia, lipoprotein oxidation and blood vessel inflammation and methods for making and using them |
| 07/03/2008 | WO2008017859A3 Ligand for the g6b receptor on blood platelets |
| 07/03/2008 | WO2007064696A3 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 07/03/2008 | US20080163387 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 07/03/2008 | US20080161421 Tcell mediator/modulator assay based upon Tcell restricted transgenic mouse |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance |
| 07/03/2008 | US20080160616 Using sited directed insertion of vectors as tool in generating transgenic cell lines |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160595 Enzymatic polypeptide for use as diagnostic tool in screening parasiticides |
| 07/03/2008 | US20080160592 Class of enzymes in the biosynthetic pathway for the production of triacylglycerol and recombinant DNA molecules encoding these enzymes |
| 07/03/2008 | US20080160054 vectors or transgenic organisms; biosynthesis; derived from Physcomitrella |
| 07/03/2008 | US20080160034 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 07/03/2008 | CA2673525A1 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 07/02/2008 | EP1939299A1 Trpm4-deficient transgenic mammals and use thereof |
| 07/02/2008 | EP1939287A1 Gene transfer method specific to trophectodermal cell |
| 07/02/2008 | EP1937717A2 Penumbra nucleic acid molecules, proteins and uses thereof |
| 07/02/2008 | EP1811833A4 Transgenic non-human animal models of ischemia-reperfusion injury and uses thereof |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | CN101210254A Trap vector and gene trapping method by using the same |
| 07/02/2008 | CN101209032A Method for breeding a kind of calm hybridized by cristaria plicata and anodonta woodianapa cifica |
| 07/02/2008 | CN100397985C Separation method of young ground beetles |
| 07/02/2008 | CN100397984C Method of measuring hatching rate, slush rate and death rate of brine shrimp simultaneously |
| 07/01/2008 | US7393994 Animal model for use in the diagnosis and treatment of nervous system disorders |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393928 Recombinant gelatins |
| 07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
| 07/01/2008 | US7393683 Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 06/26/2008 | WO2008076761A1 Mouse model for human breast cancer |
| 06/26/2008 | WO2008074880A2 Transgenic animal model |
| 06/26/2008 | WO2008074813A2 Optiogenin for the treatment of neural diseases |
| 06/26/2008 | WO2008031430A3 Doubly transgenic non-human mammal |
| 06/26/2008 | US20080155716 Serine hydroxymethyltransferase as target for herbicides |
| 06/26/2008 | US20080155705 Method For the Production of Multiple-Unsaturated Fatty Acids in Transgenic Organisms |
| 06/26/2008 | US20080155704 BiP is a human molecular chaperone known variously as binding immunoglobulin protein (BiP) or glucose regulated protein (Grp)78 that has antiinflammatory effect; used to monitor the therapeutic effect of BiP; markers in a blood sample may indicate that a subject is responsive to BiP |
| 06/26/2008 | US20080155703 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 06/26/2008 | US20080153764 Used in cells and transgenic animals for a variety of applications including producing and studying the effects of RNAi and microRNA mediated gene silencing. |
| 06/26/2008 | US20080153167 In vivo amplification of neural progenitor cells |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152643 Using modulators of toll-like receptor and/or uncooridinated protein activities as therapeutic agents in treatment of diabetes, multiple sclerosis, rheumatoid arthritis and addison's diseases |
| 06/26/2008 | US20080152625 Swine Population Having Low Levels of Porcine Endogenous Retrovirus and Uses Thereof |
| 06/26/2008 | CA2673174A1 Artificial selection method and reagents |
| 06/26/2008 | CA2672509A1 Tissue-specific and temporal control of transgene expression in a model -animal |
| 06/26/2008 | CA2669921A1 Human monoclonal antibodies to btla and methods of use |
| 06/25/2008 | EP1935244A1 Animal model of schizophrenia |
| 06/25/2008 | EP1935243A1 Saspase knockout animal |
| 06/25/2008 | EP1935242A1 Transgenic animal model |
| 06/25/2008 | EP1934594A2 An animal model for studying atherosclerotic lesions |
| 06/25/2008 | EP1934358A2 Transgenic rosa26-luciferase mice for bioluminescent imaging |
| 06/25/2008 | EP1171609B1 Lipoxygenase proteins and polynucleotides encoding the same |
| 06/25/2008 | CN101204585A Method of building animal model for parkinsonism |
| 06/25/2008 | CN101204195A Rapid biological treatment of food market garbage |
| 06/25/2008 | CN101204142A Producing method for movable-framed tsuchiana hive |
| 06/25/2008 | CN100396178C Complete artificial method for breeding Ciona and simple continuous bait scattering device |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/19/2008 | WO2008072781A1 Method for prevention or treatment of memory disorder in mammal |
| 06/19/2008 | WO2008072714A1 Temperature sensor, living body health managing system |
| 06/19/2008 | WO2008072712A1 Radio sensor system, living body health managing system |
| 06/19/2008 | WO2008072705A1 Acceleration sensor, and avian influenza monitoring system |
| 06/19/2008 | WO2008071771A2 Inhibition of gpr4 |
| 06/19/2008 | WO2008071201A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| 06/19/2008 | WO2008027807A3 Control of diabetes and obesity |
| 06/19/2008 | WO2008015393A3 Method for rearing predatory mites |
| 06/19/2008 | WO2001034766A3 Protein monitoring the activity of small gtp-binding protein |
| 06/19/2008 | US20080148418 Inbreeding transgenic fish and monitoring recombinant offspring; generating animal model for use in drug screening |
| 06/19/2008 | US20080148417 Rodent animal model comprising mutation in colinergic receptor nicotinic alpha-4 (CHRNA4) gene for use in identifying modulator for prevention and treatment of seizure disorders |
| 06/19/2008 | US20080148416 Animal models for monitoring activity of drug metabolizing enzymes; side effect reduction; assessing xenobiotics |
| 06/19/2008 | US20080147458 Breeding support system |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | US20080145888 Assessment method |
| 06/19/2008 | US20080145860 Encapsulated cell indicator system |
| 06/19/2008 | US20080145858 Using cleavage stage embryos as bioreactors/models for sceening teratogenic compounds |
| 06/19/2008 | US20080145855 Mutations in the Ferroportin 1 Gene Associated with Hereditary Haemochromatosis |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/18/2008 | EP1932915A2 Materials and methods relating to improved vaccination strategies |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932911A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/18/2008 | EP1932906A1 Method for producing nuclear-transplanted egg |
| 06/18/2008 | EP1932544A1 Gene transfer for treating a connective tissue of a mammalian host |
| 06/18/2008 | CN201075186Y Temperature and humidity automatic controller |
| 06/18/2008 | CN201072952Y Constant water level humiture automatic control machine |
| 06/18/2008 | CN201072951Y Temperature and humidity regulating apparatus |
| 06/18/2008 | CN201072950Y Constant water level humidification machine |
| 06/17/2008 | US7388124 Adjustment, compression of nervous systems; detection, monitoring variations in pain |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/12/2008 | WO2008070385A2 Uses of a murine model of hiv-1 infection |
| 06/12/2008 | WO2008069659A1 Improved xenogenic immune system in a non-human mammal |
| 06/12/2008 | WO2008067651A1 Gender selection with the use of antibodies |
| 06/12/2008 | WO2007135561A3 Animal breeding system and method |
| 06/12/2008 | WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 06/12/2008 | WO2007028656A3 Animal model and method for testing drugs and treatments for neurodevelopment disorders |
| 06/12/2008 | US20080141386 Chromosomal Loci For The Stringent Control Of Gene Activities Via Transcription Activation Systems |
| 06/12/2008 | US20080141385 Determining if compound is activator or inhibitor of oxidative stress response by detecting expression of transgene in nematode; screening for antioxidants |
| 06/12/2008 | US20080141384 Composition For Screening Anti-Hypertension Drug Comprising Mammal Tctp Gene or Its Protein Product, and Method For Screening Anti-Hypertension Drug Using Said Composition |
| 06/12/2008 | US20080139492 Nucleobase oligomeric compositions useful in enhancing RNA interference in a wide variety of cell types for treatment of virtually any disease or disorder related to overexpression of a gene or genes, as well as methods of identifying and using such compositions |
| 06/12/2008 | US20080139469 Containing fibroblast growth factor or partial peptide active ingredient; promoting follicle growth |
| 06/12/2008 | US20080138358 Protective protein comprising protease sequences from newly excysted juveniles for use in vaccination and prevention of parasitic infection of gut tissues |